Stockreport

Albireo Reports Q2 Financial Results and Business Update

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF – BylvayTM (odevixibat) approved in U.S. & EU as only once-daily drug indicated for patients with PFIC – – Commercialization underway with Bylvay, first prescriptions r [Read more]